EyeWorld Weekly, June 12, 2026

➤ First patient dosed in Phase 3 trial evaluating cenegermin for PCED ➤ First patient dosed in Phase 3 study for Stargardt treatment ➤ First patient randomized into registrational trial for first-in-class dry eye therapy ➤ FDA clears new software for retinal imaging machine ➤ Company news ➤ ASCRS news and events ➤ EyeWorld article of the week